EFFECT OF STATINS ON SERUM CONCENTRATION OF INFLAMMATORY MARKERS AND MATRIX METALLOPROTEINASES IN PATIENTS WITH ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION

Aim. To assess the effect of pre-hospital administration of statins on the levels of inflammatory markers and matrix metalloproteinases in the se-rum of patients with acute ST-segment elevation myocardial infarction (STEMI).Materials and Methods. We consecutively recruited 175 patients with STEMI (116 (66.3%) men and 59 (33.7%) women, average age 61.3 ± 8.4 years). Serum concentrations of interleukins (IL-6, IL-10, IL-12), C-reactive protein (CRP), tu-mor necrosis factor-α (TNF-α), and matrix metal-loproteinases (MMP-1, -3, -9) as well as blood lipid parameters were evaluated in all patients at the admission and on 12th day after STEMI onset. All the patients were divided into 2 groups depending on pre-hospital use of statins: 136 (77.71%) patients without and 39 (22.29%) patients with statin administration.Results. As compared to the patients without prior statin treatment, those who used statins ≥ 7 days prior to the development of STEMI had significantly lower values of serum low-density lipoproteins [2.91 (1.31; 5.13) vs 1.34 (0.76; 9.77), respectively], IL-6, CRP, TNF-α, and MMP-9 at both time points. In keeping with these ndings, serum level of anti-inflammatory marker IL-10 was two-fold higher in patients taking statins at the pre-hos-pital stage in comparison with those without statin administration. Conclusions. The lack of pre-hospital statin administration in patients with STEMI is associated with the higher values of pro-inflammatory markers (IL-6, CRP, TNF-α), and MMP-9 during in-hospital period.

инфаркт миокарда, статины, матриксные металлопротеиназы, маркеры воспаления, myocardial infarction, statins, matrix metalloproteinases, inflammatory markers

1. Bertelsen DM, Neergaard JS, Bager CL, Nielsen SH, Secher NH, Svendsen JH, at al. Matrix Metalloproteinase Mediated Type I Collagen Degradation is an Independent Predictor of Increased Risk of Acute Myocardial Infarction in Postmenopausal Women. Sci Rep. 2018; 8 (1): 5371. doi: 10.1038/s41598-018-23458-4

2. Hamed GM, Fattah MF. Clinical Relevance of Matrix Metalloproteinase 9 in Patients With Acute Coronary Syndrome. Clin Appl Thromb Hemost 2015; 21 (8): 705-711. doi: 10.1177/1076029614567309

3. Shrivastava AK, Singh HV, Raizada A, Singh SK. Serial measurement of lipid profile and inflammatory markers in patients with acute myocardial infarction. EXCLI J. 2015; 14: 517-526. doi: 10.17179/excli2014-671

4. Chacón-Piñero A, Nogales-Asensio JM, Martínez-Carapeto A, Lledó-Gómez M, Merchán-Cuenda M, Bengla-Limpo B. Current Management of Hyperlipidemia in Patients Discharged With a Diagnosis of Acute Coronary Syndrome. Rev Esp Cardiol. 2016; 69 (1): 83-84. doi: 10.1016/j.rec.2015.09.009

5. Pitt B, Loscalzo J, Ycas J, Raichlen JS. Lipid levels after acute coronary syndromes. J Am Coll Cardiol. 2008; 51 (15): 1440-1445. doi: 10.1016/j.jacc.2007.11.075

6. Wang WT, Hellkamp A. Doll JA, Thomas L, Navar AM, Fonarow GC, et al. Lipid Testing and Statin Dosing After Acute Myocardial Infarction. J Am Heart Assoc. 2018; 7 (3): e006460. doi: 10.1161/JAHA.117.006460

7. Geovanini GR, Libby P. Atherosclerosis and inflammation: overview and updates. Clin Sci (Lond). 2018; 132 (12): 1243-1252. doi: 10.1042/CS20180306

8. Shrivastava AK, Singh HV, Raizada A, Singh SK. C-reactive protein, inflammation and coronary heart disease. Egyptian Heart J. 2015; 67 (2): 89-97. doi:10.1016/j.ehj.2014.11.005

9. Han X, Zhang Y, Yin L, Zhang L, Wang Y, Zhang H, et al. Statin in the treatment of patients with myocardial infarction. Medicine (Baltimore). 2018; 97 (12): e0167. doi: 10.1097/MD.0000000000010167

10. Libby P, Ridker MP, Hansson GK, Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis. From pathophysiology to practice. J Am Coll Cardiol. 2009; 54 (23): 2129-2138. doi: 10.1016/j.jacc.2009.09.009

11. Pollanen PJ, Karhunen PJ, Mikkelsson J, Laippala P, Perola M, Penttilä A, et al. Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene. Arterioscler Thromb Vasc Biol. 2001; 21 (9): 1446-1450. https://doi.org/10.1161/hq0901.095545

12. Nordmann A, Schwartz G, Vale N, Bucher HC, Briel M. Cochrane corner: early statin therapy in acute coronary syndromes-what is the clinical benefit? Heart 2016; 102 (9): 653-654. doi: 10.1136/heartjnl-2015-307781